Hypoxia-induced carbonic anhydrase IX facilitates lactate flux in human breast cancer cells by non-catalytic function

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jamali, Somayeh ^a   Klier, Michael ^a   Ames, Samantha ^a   Felipe Barros, L ^b   McKenna, Robert ^c   Deitmer, Joachim W ^a   Becker, Holger M ^a  

^a University of Koblenz Landau   (Germany)

^b CENTRO DE ESTUDIOS CIENTÍFICOS CECS   (Chile)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; LACTIC ACID; OXYGEN; TUMOR ANTIGEN;

BREAST TUMOR; CATALYSIS; CELL HYPOXIA; CELL SURVIVAL; ENERGY METABOLISM; ENZYME ACTIVATION; HUMAN; MCF-7 CELL LINE; METABOLIC CLEARANCE RATE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARBONIC ANHYDRASE IX; CARBONIC ANHYDRASES; CATALYSIS; CELL HYPOXIA; CELL SURVIVAL; ENERGY METABOLISM; ENZYME ACTIVATION; HUMANS; LACTIC ACID; MCF-7 CELLS; METABOLIC CLEARANCE RATE; OXIDATIVE STRESS; OXYGEN;

EID: 84941114841     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13605     Document Type: Article

References (71)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
2. Schulze, A. & Harris, A. L. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491, 364-373 (2012).
3. Parks, S. K., Chiche, J. & Pouysségur, J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat. Rev. Cancer 13, 611-623 (2013).
4. Brahimi-Horn, M. C., Bellot, G. & Pouysségur, J. Hypoxia and energetic tumour metabolism. Curr. Opin. Genet. Dev. 21, 67-72 (2011).
5. Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899 (2004).
6. Cardone, R. A., Casavola, V. & Reshkin, S. J. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat. Rev. Cancer 5, 786-795 (2005).
7. Parks, S. K., Chiche, J. & Pouyssegur, J. pH control mechanisms of tumor survival and growth. J. Cell. Physiol. 226, 299-308 (2011).
8. Warburg, O., Wind, F. & Negelein, E. The Metabolism of Tumors in the Body. J. Gen. Physiol. 8, 519-530 (1927).
9. Weinhouse, S., Warburg, O., Burk, D. & Schade, A. L. On respiratory impairment in cancer cells. Science 124, 269-270 (1956).
10. Poole, R. C. & Halestrap, A. P. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. 264, 761-82 (1993).
11. Ullah, M. S., Davies, A. J. & Halestrap, A. P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J. Biol. Chem. 281, 9030-9037 (2006).
12. Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T. & Sonveaux, P. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front. Pharmacol. 2, 49 (2011).
13. Gillies, R. J., Verduzco, D. & Gatenby, R. A. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat. Rev. Cancer 12, 487-493 (2012).
14. Kennedy, K. M. & Dewhirst, M. W. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol. 6, 127-148 (2010).
15. Ward, C. et al. New strategies for targeting the hypoxic tumour microenvironment in breast cancer. Cancer Treat. Rev. 39, 171-179 (2012).
16. Reshkin, S. J. et al. Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 14, 2185-2197 (2000).
17. Chiche, J., Brahimi-Horn, M. C. & Pouysségur, J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J. Cell. Mol. Med. 14, 771-794 (2010).
18. Boedtkjer, E., Bunch, L. & Pedersen, S. F. Physiology, pharmacology and pathophysiology of the pH regulatory transport proteins NHE1 and NBCn1: similarities, differences, and implications for cancer therapy. Curr. Pharm. Des. 18, 1345-1371 (2012).
19. Gorbatenko, A., Olesen, C. W., Boedtkjer, E. & Pedersen, S. F. Regulation and roles of bicarbonate transporters in cancer. Front. Physiol. 5, 130 (2014).
20. Sedlakova, O. et al. Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors. Front. Physiol. 4, 400 (2014).
21. Morgan, P. E., Pastorekova, S., Stuart-Tilley, A. K., Alper, S. L. & Casey, J. R. Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters. Am. J. Physiol. Cell Physiol. 293, 738-48 (2007).
22. Swietach, P., Hulikova, A., Vaughan-Jones, R. D. & Harris, A. L. New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. Oncogene 29, 6509-6521 (2010).
23. Swietach, P., Vaughan-Jones, R. D., Harris, A. L. & Hulikova, A. The chemistry, physiology and pathology of pH in cancer. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 369, 20130099 (2014).
24. Svastova, E. et al. Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain. J. Biol. Chem. 287, 3392-3402 (2012).
25. Stock, C. & Schwab, A. Protons make tumor cells move like clockwork. Pflügers Arch. 458, 981-992 (2009).
26. Martin, C., Pedersen, S. F., Schwab, A. & Stock, C. Intracellular pH gradients in migrating cells. Am. J. Physiol. Cell Physiol. 300, 490-495 (2011).
27. Neri, D. & Supuran, C. T. Interfering with pH regulation in tumours as a therapeutic strategy. Nat. Rev. Drug Discov. 10, 767-777 (2011).
28. Bröer, S. et al. Comparison of lactate transport in astroglial cells and monocarboxylate transporter 1 (MCT 1) expressing Xenopus laevis oocytes. Expression of two different monocarboxylate transporters in astroglial cells and neurons. J. Biol. Chem. 272, 30096-30102 (1997).
29. Bröer, S., Schneider, H., Bröer, A. & Deitmer, J. W. Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH. Biochem. J. 174, 167-174 (1998).
30. Carpenter, L. & Halestrap, A. P. The kinetics, substrate and inhibitor specificity of the lactate transporter of Ehrlich-Lettre tumour cells studied with the intracellular pH indicator BCECF. Biochem. J. 304, 751-760 (1994).
31. Bröer, S. et al. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem. J. 535, 529-535 (1999).
32. Dimmer, K. S., Friedrich, B., Lang, F., Deitmer, J. W. & Bröer, S. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem. J. 350, 219-227 (2000).
33. Becker, H. M., Klier, M., Schüler, C., McKenna, R. & Deitmer, J. W. Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II. Proc. Natl. Acad. Sci. USA 108, 3071-3076 (2011).
34. Bittner, C. X. et al. High resolution measurement of the glycolytic rate. Front. Neuroenergetics 2, 1-11 (2010).
35. San Martín, A. et al. A genetically encoded FRET lactate sensor and its use to detect the Warburg effect in single cancer cells. PLoS One 8, e57712 (2013).
36. Draoui, N. et al. Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux. Mol Cancer Ther 13, 1410-1418 (2014).
37. Gallagher, S. M., Castorino, J. J., Wang, D. & Philp, N. J. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 67, 4182-4189 (2007).
38. Stridh, M. H. et al. Lactate flux in astrocytes is enhanced by a non-catalytic action of carbonic anhydrase II. J. Physiol. 590, 2333-2351 (2012).
39. Syková, E. & Nicholson, C. Diffusion in brain extracellular space. Physiol. Rev. 88, 1277-1340 (2008).
40. Pastorekova, S. et al. Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. Bioorg. Med. Chem. 16, 3530-3536 (2008).
41. Vaupel, P., Kallinowski, F. & Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465 (1989).
42. Höckel, M. & Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93, 266-276 (2001).
43. Walenta, S. et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am. J. Pathol. 150, 409-415 (1997).
44. Walenta, S. et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60, 916-921 (2000).
45. Brizel, D. M. et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 51, 349-353 (2001).
46. Raghunand, N. et al. Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem. Pharmacol. 57, 309-312 (1999).
47. Schornack, P. A. & Gillies, R. J. Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia 5, 135-145 (2003).
48. Storci, G. et al. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J. Pathol. 214, 25-37 (2008).
49. Tafani, M. et al. Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment. Cancer Sci. 101, 1014-1023 (2010).
50. Cheng, Y. et al. Oroxylin A inhibits hypoxia-induced invasion and migration of MCF-7 cells by suppressing the Notch pathway. Anticancer. Drugs 25, 778-789 (2014).
51. Ghattass, K. et al. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway. Mol. Cancer 13, 12 (2014).
52. Dong, X. L. et al. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1. Biomed. Pharmacother. 66, 70-75 (2012).
53. Mitani, T. et al. Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells. J. Nutr. Sci. Vitaminol. (Tokyo). 60, 122-128 (2014).
54. Rosafio, K. & Pellerin, L. Oxygen tension controls the expression of the monocarboxylate transporter MCT4 in cultured mouse cortical astrocytes via a hypoxia-inducible factor-1α -mediated transcriptional regulation. Glia 62, 477-490 (2013).
55. Pinheiro, C. et al. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56, 860-867 (2010).
56. Pinheiro, C. et al. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J. Biomed. Biotechnol. 2010, 427694 (2010).
57. Pinheiro, C. et al. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histol. Histopathol. 26, 1279-1286 (2011).
58. Le Floch, R. et al. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc. Natl. Acad. Sci. USA 108, 16663-16668 (2011).
59. Schneiderhan, W. et al. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models. Gut 58, 1391-1398 (2009).
60. Abbate, F., Casini, A., Owa, T., Scozzafava, A. & Supuran, C. T. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 14, 217-223 (2004).
61. Talbot, D. C. et al. A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancer. Clin. Cancer Res. 13, 1816-1822 (2007).
62. Polański, R. et al. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer. Clin. Cancer Res. 20, 926-937 (2014).
63. Takanaga, H., Chaudhuri, B. & Frommer, W. B. GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim. Biophys. Acta 1778, 1091-1099 (2008).
64. Becker, H. M., Bröer, S. & Deitmer, J. W. Facilitated lactate transport by MCT1 when coexpressed with the sodium bicarbonate cotransporter (NBC). in Xenopus oocytes. Biophys. J. 86, 235-247 (2004).
65. Becker, H. M. Transport of Lactate: Characterization of the transporters involved in transport at the plasma membrane by heterologous protein expression in Xenopus oocytes. In: Hirrlinger J., Waagepetersen H. (eds) Neuromethods: Brain Energy Metabolism, Springer (2014).
66. Okuyama, T., Sato, S., Zhu, X. L., Waheed, A. & Sly, W. S. Human carbonic anhydrase IV: cDNA cloning, sequence comparison, and expression in COS cell membranes. Proc. Natl. Acad. Sci. USA 89, 1315-1319 (1992).
67. Osborne, W. R. & Tashian, R. E. An improved method for the purification of carbonic anhydrase isozymes by affinity chromatography. Anal. Biochem. 64, 297-303 (1975).
68. Deitmer, J. W. Electrogenic sodium-dependent bicarbonate secretion by glial cells of the leech central nervous system. J. Gen. Physiol. 98, 637-655 (1991).
69. Silverman, D. N. Carbonic anhydrase: oxygen-18 exchange catalyzed by an enzyme with rate-contributing proton-transfer steps. Methods Enzymol. 87, 732-752 (1982).
70. Sültemeyer, D. F., Fock, H. P. & Canvin, D. T. Mass Spectrometric Measurement of Intracellular Carbonic Anhydrase Activity in High and Low C(i) Cells of Chlamydomonas: Studies Using O Exchange with C/O Labeled Bicarbonate. Plant Physiol. 94, 1250-1257 (1990).
71. Badger, M. R. & Price, G. D. Carbonic Anhydrase Activity Associated with the Cyanobacterium Synechococcus PCC7942. Plant Physiol. 89, 51-60 (1989).